Abstract
Although the cardiac biomarker troponin T (cTnT) is related strongly to mortality in patients with end-stage renal disease, the independent association of N-terminal pro–B-type natriuretic peptide (NT–pro-BNP) and cTnT levels in predicting outcomes is unknown. The objective of this study is to determine factors associated with NT–pro-BNP and cTnT and determine whether these levels are associated with mortality.Cohort study.Asymptomatic hemodialysis patients (n = 150) in 4 university-affiliated hemodialysis units.For cross-sectional analysis, echocardiographic variables as exposures and NT–pro-BNP and cTnT levels as outcomes; for longitudinal analysis, association of NT–pro-BNP and cTnT levels as exposures to all-cause and cardiovascular disease mortality as outcomes.In a multivariate regression analysis, low midwall fractional shortening, a measure of poor systolic function, was an independent correlate of log NT–pro-BNP level (P < 0.01), whereas left ventricular mass index was an independent correlate of cTnT level (P < 0.01). During a median follow-up of 24 months, 46 patients died, 26 of cardiovascular causes. NT–pro-BNP levels had a strong graded relationship with all-cause (hazard ratios [HRs], 1.54, 4.78, and 4.03 for increasing quartiles; P < 0.001) and cardiovascular mortality (HRs, 2.99, 10.95, and 8.54; P < 0.01), whereas cTnT level had a weaker relationship with all-cause (HRs, 1.57, 2.32, and 3.39; P < 0.01) and cardiovascular mortality (HRs, 0.81, 2.12, and 2.14; P = 0.1). The combination of the 2 biomarker levels did not improve the association with all-cause or cardiovascular mortality compared with NT–pro-BNP level alone. NT–pro-BNP level was a marker of mortality even after adjusting for left ventricular mass index and midwall fractional shortening.Our cohort was predominantly black and of limited sample size.NT–pro-BNP level strongly correlates with left ventricular systolic dysfunction and is associated more strongly with mortality than cTnT level in asymptomatic hemodialysis patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.